399
2615583226014562120173
Ces37297936014570127174
Urol39287936014578115180208
2023;41617936014562121178238260
27(3):44467936014562119147205234256
251-26147287936014561121176207262320374
PŮVODNÍ4031207016974172259362464566608
PRÁCE4686207016974156253339415
10.624896013356107129
Petrelli775896013359111148183237263288313
F,111089601335466
Coinu1198896013364123148208268
A,148889601336792
Cabiddu1602896013364117179204266328388
M,2012896013388112
et214789601335591
al.226089601335379101
Correlation2384898013163119151183235257306338360418476
of288389801315987
pathologic2993898013161111143201259282340401422471
complete3487898013149105194254277330363414
response392489801313284124183242301340393
with4340898013180102135193
survival455689801314198129182205254304326
after490589801315078116167198
neoadjuvant6241048013159112171221280303359409459516548
chemotherapy12031048013149107160249308340398451483532592639
in1873104801312381
bladder1985104801316184132192251304336
cancer2352104801314998156205256287
treated2670104801313466117166198249309
with30101048013179102135193
cystectomy:3235104801314999140175226275311367457503522
a37891048013149
meta‑analysis.38701048013190143176226259307365414436484525546585605
Eur45061048013151106137
Urol.4675104801316899156179197
201449031048013154106153200
Feb;6241198013151102162179
65(2):8271198013154105131182208225
350–7.10761198013154103155213260267
doi:13671198013160118141158
1.1016/j.eururo.2013.1549119801315366112159207253291315333386443474533564621638693745792837854
06.24281198013153108127
049.25791198013153109159174
11.6241346013356101118
Hermans7691346013372127163255307367410
TJ,1206134601335588109
Fransen1342134601335487139200242297358
van17271346013353106166
de19201346013362117
Putte20641346013358118154192246
EE,23371346013354107129
et2493134601335592
al.2612134601335378101
Pathological27401348013155103135193252275333393415463513535
downstaging33031348013160118196255294329378438460517577
and39071348013150108168
survival4102134801314298129182205254304326
after4456134801315078116167198
induction4682134801312380140197245282304361420
chemotherapy6241498013149107160249307339397450482532591638
and12831498013150107167
radical1470149801313382142164212262284
cystectomy17741498013149100141175226275312368457503
for2298149801312986118
clinically243614980131497193150172220270292313361
node‑positive28181498013159117177230264325385425446479501550602
bladder3441149801316083132191251304335
cancer‑Results3796149801314999157205256287316373426466522544578619
of4436149801315887
a45431498013150
nationwide46131498013159108140162220278355378437490
population‑based6241648013161120180238260309341363421480513574624664717777
study.1425164801314176133193241255
Eur17041648013151106137
J18661648013138
Cancer.19281648013162112170218269301315
2016;22671648013154105153199217
69:25081648013154105124
1-8.2656164801315380135154
doi:28341648013160118141158
10.1016/j.ejca.2016.30161648013153101118164212259306343367385438460509558577632684731778797
09.38371648013154107122
015.39831648013154102147163
12.6241796013356104127
Herr7731796013372127163199
HW,9941796013371164182
Faulkner11971796013354102162187238300355391
JR,16101796013340100125
Grossman17561796013371108167210252343396456
HB,22341796013372131154
et2409179601335692
al.2523179601335378101
Surgical26461798013151108139197219267317339
factors3008179801312879128164220252293
influence3323179801312381106133190243301349400
bladder3746179801316184132192251304336
cancer4104179801314999157205256288
outcomes:44141798013159117150197252342395436453
a48901798013150
co‑49621798013149105140
operative6241948013159119173204254286308358409
group1058194801315991147205265
report.1347194801313284143203235272291
J16621948013138
Clin1724194801316284106163
Oncol19111948013174133182238261
2004;21961948013154105160215232
22(14):24521948013154106132179226251268
2781–2789.27441948013153103153201251298348398450465
13.6242096013356103124
Gschwend7672096013370112160219297350409470
JE,1255209601334194116
Heck13892096013371125174224
MM,16312096013388175198
Lehmann18472096013352105165254305365424
J,2289209601334161
et2369209601335490
al.247720960133537799
Extended2595209801315199135184241299351410
Versus30252098013155103134174229267
Limited3312209801314870157178211261320
Lymph3651209801314990179237295
Node39652098013169126186237
Dissection4222209801317092130169221269304326382440
in4681209801312379
Bladder4780209801315476124182241292323
Cancer6242248013163112170219270301
Patients9552248013155103135157210268299341
Undergoing13262248013169126185238270328386408465525
Radical18802248013156106165187235285307
Cystectomy:22172248013162104144179230279315371461507527
Survival27732248013151108139192215264314336
Results31392248013155109149205227261302
from3471224801312962118208
a37082248013150
Prospective,3788224801315586142182241295345381403452504521
Randomized43382248013156106163223281371392436488548
Trial.491622480131517598146168187
Eur6242398013151107138
Urol.7862398013169100156179198
201910082398013153105153198
Apr;12302398013164124156175
75(4):14292398013154103129179204220
604–611.16742398013153107162219276321362374
doi:20722398013160118141158
10.1016/j.eururo.2018.22542398013153101118164212259306343367386438496527585616673691745797845891910
09.31892398013153107122
047.33352398013154109157164
14.6242546013356106128
Sternberg774254601335489142178239301356392453
CN,12492546013364135158
de14292546013362117
Mulder15682546013388149174236291326
PH,19162546013359129152
Schornagel20902546013354104164224260321373434489515
JH,26272546013341112136
et2785254601335591
al.2898254601335379101
Randomized30212548013156105163222280370392436487547
phase35912548013161120168208261
III387525480131234567
trial396525480131346689137159
of4147254801315887
high‑dose‑intensity4257254801315980139197230292350390443478501559591642700739760794845
methotrexate,6242698013191145178237296329361413461511544596613
vinblastine,1269269801315074132192215265305340362421474491
doxorubicin,17932698013160119165222255314374397446468526544
and23702698013150109169
cisplatin2571269801315072112171195244277299357
(MVAC)29612698013129113168227287318
chemotherapy33112698013150108162252311344402456488538599647
and39902698013150109169
recombinant4192269801313285135191282342365423473531563
human47882698013159117207256315
granulocyte624284801316091141199256278336385436474525
colony‑stimulating11712848013149105128186244290323363398420509566588636669691748808
factor2001284801312879128164220252
versus22752848013150101133174230269
classic2566284801315072120160200221269
MVAC28572848013186141199258
in3137284801312381
advanced32402848013150109159208266315366426
urothelial3688284801315890146179237290312334382404
tract4114284801313466116165201
tumors:4337284801313491180239271312329
European46882848013151107138195255309357415
Organisation6242998013174106164213271292331382414436493552
for1199299801312886118
Research13392998013156109149202250281328386
and17472998013150108168
Treatment1937299801315176127175208297350408440
of2399299801315987
Cancer25092998013163112170219270301
Protocol2833299801315585142174230280336359
No.32142998013170129147
3092433832998013154106159209257
J36592998013138
Clin3720299801316385106164
Oncol.39062998013174133181237260279
2021;42072998013154106155202213
19:4442299801315499118
2638–45822998013154105156208264
2646.48692998013153104160215234
15.6243146013356105126
Pfister770314601335888117160197250286
C,1076314601336488
Gravis11843146013371107160210236279
G,1482314601337195
Fléchon1597314601335478133182242303363
A,1980314601336892
et2092314601335591
al.2203314601335379101
VESPER23243148013156108159212261314
Trial265931480131517698146169
Investigators.2848314801312381128180220255277336385417473505546566
Dose‑Dense34343148013171130170223258330384442481534
Methotrexate,39883148013186139172230289321353404452501534585601
Vinblastine,4610314801315680137197220269308343365422476492
Doxorubicin,6243298013171130175232264322381404452474531549
and11943298013150107167
Cisplatin1381329801316385124183206254286308366
or1767329801315991
Gemcitabine18783298013169123211260282315365424447504557
and24563298013149107167
Cisplatin2643329801316385123183206254286308366
as3029329801315090
Perioperative31393298013155106137160217277331363413445467516568
Chemotherapy37273298013163120173262320353411464495545604652
for4399329801312986118
Patients45373298013155103135157210268300341
With48993298013190113146204
Nonmetastatic6243448013170129187276329362412451486536568590638
Muscle‑Invasive12863448013185143182231253306340365422470519559580630682
Bladder1991344801315679127187246299330
Cancer:23453448013163113170219270301321
Results26903448013155108149205227260302
of3016344801315887
the3126344801313492145
GETUG‑AFU32953448013169119173242310345408457524
V0538423448013156109160
VESPER40263448013156108159212261314
Trial.436434480131517698147169187
J45753448013138
Clin4637344801316284106163
Oncol.48243448013174133181237260279
20226243598013154105155208
Jun856359801313895153
20;10333598013154105124
40(18):11813598013153108137184231257274
2013–2022.14793598013154105153198253300352401454471
doi:19753598013159117140157
10.1200/JCO.21.02051.21563598013154101119165209261316352382445514530585632645698747799851897910
16.6243746013356106129
Necchi7723746013372127176223283307
A,1099374601336791
Anichini12093746013367127152200260284344369
A,1597374601336791
Raggi17083746013359111172232257
D,1984374601337392
et2095374601335591
al.220637460133527799
Pembrolizumab23253748013155105193253284340363384428485574622681
as3026374801315089
Neoadjuvant31353748013170123181231290311368417466523555
Therapy37103748013151110163194243302349
Before40793748013155108136193224275
Radical43743748013155105164185233282304
Cystecto‑46983748013162103144178228277313369404
my6243898013190136
in782389801312380
Patients8843898013155103135157210268300341
With12473898013190113147205
Muscle‑Invasive14733898013186143183231254306341365423470520560581630682
Urothelial2177389801316899156188246299322343392414
Bladder2612389801315679127187246299331
Carcinoma29643898013163112144190212270328418467
(PURE-01):3452389801312983150204255287344391411428
An39023898013164122
Open‑Label,40463898013173134188246279330380440494517534
Single‑Arm,4602389801315172129189211264298361393483501
Phase6244048013155112161200254
II902404801312345
Study.971404801315182140199248261
J12564048013138
Clin1318404801316385106164
Oncol.15064048013174133181237260278
2018;18094048013153105153199216
36:20494048013154106124
3353.21974048013153103153203220
17.6244196013356104115
Powles7654196013358116196222277320
T,1111419601335470
Kockx12074196013360118168219274
M,15074196013388112
Rodriguez‑Vida16454196013359120182217243304364419466499558585647699
A,2370419601336792
et2488419601335591
al.2605419601335379101
Clinical2732419801316385106164185234283306
efficacy3064419801315481109137185235284334
and34254198013150108167
biomarker3619419801316183141231280311357409440
analysis40864198013150107156178226267288327
of4440419801315887
neoadjuvant45544198013159112171221280302359408458516548
atezolizumab624434801315082133178234257279323381470519578
in1226434801312381
operable13314348013158119173204254314337390
urothelial1745434801315889146178236289312334382404
carcinoma2173434801314999130177199256314404453
in2650434801312381
the2755434801313492145
ABACUS29244348013164119181240307355
trial.330343480131346689137159177
Nat35054348013170119151
Med.36804348013186139199218
2019;39224348013154105153198216
25:41624348013154107122
1706.4308434801315497147201220
18.6244496013356106129
Powles7724496013358115194220274316
TB,11084496013354113135
PerezValderamma12624496013359111146200246307356381442496532584674764816
B,2097449601336082
Gupta21984496013370131192227280
S,2497449601335476
et2592449601335591
al.2702449601335378100
EV-302/KEYNOTE‑A39:28214498013151108138186238287326381432488557630678729760823876926944
Open‑label,37854498013173133187244277300348408461483500
randomized4305449801313282139198255344365408459519
phase48444498013160118166206258
36244648013154
study699464801314176133193241
of961464801315987
enfortumab10704648013153111139196228265323412460520
vedotin16114648013150102162220253275332
in1965464801312380
combination20674648013149105194254277334383415437495553
with26424648013179102135193
pembrolizumab28564648013161115204264296352375397441499588637696
(EV+P)3574464801312979136197250276
vs3872464801314990
chemotherapy39834648013149107160249307340398451482532592639
(chemo)4643464801312974132185274332358
in5022464801312381
previously624479801316193144193216274332371393441
untreated10954798013159116148180231279312363423
locally1548479801312482131181203225273
advanced18514798013150110159209267315366426
metastatic23084798013190143176226265300350382404452
urothelial2791479801315889146178236289312333382404
carcinoma3225479801314999130177199256315404453
(la/mUC).3708479801313053101141227294356387402
ESMO41404798013151103186260
Congress.44304798013163119177237268319360399419
2023;48794798013154106155208224
Abstract6244948013164124164199231281329365
LBA6.10144948013149103166217236
19.6245096013356106125
Crozier780509601336398158203228283319
J,1130509601334162
Papa12235096013358110172225
N,1479509601337295
Perera16055096013359111147201237290
M,19265096013388112
et2069509601335592
al.2192509601335378100
Comparative23245098013163119208268318349399431453503554
sensitivity2910509801314194152192213246268318340374425
and33675098013150108167
specificity35665098013141100154204226251278327348382433
of4031509801315887
imaging41505098013123111160220241299358
modalities45405098013190149209258280302335357410450
in5022509801312380
staging624524801314176125185206264323
bladder974524801316084132192251304335
cancer1336524801314999156205256287
prior1650524801316092115173205
to1881524801313490
radical1997524801313383142164212262284
cystectomy:23085248013149100140175226275311367457503523
a28575248013150
systematic2933524801314191131166217306355387409457
review3417524801313284132155208286
and37305248013149107167
meta‑analysis.39235248013190143176226259308366415437485526547586605
World45555248013190145177200259
J48415248013138
Urol.49055248013169100156179198
20196245398013154105153198
Apr;8465398013164124156175
37(4):10465398013153101125175200217
667–690.12875398013153107157206263314368386
doi:16975398013160118140157
10.1007/s00345-018-2439-8.1878539801315410111916521226731634538143448953959364267573278082686090695410031053108911431163